Penumbra, Inc APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Penumbra, Inc (PEN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $13.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-30
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $13.21M, a 5.67% decline year-over-year.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $17.19M, a 4.57% increase year-over-year.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $14.37M, a 43.99% increase year-over-year.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $14.01M, a 50.98% increase year-over-year.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $59.52M, a 30.54% increase from fiscal 2024.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $45.60M, a 6.16% decline from fiscal 2023.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $48.59M, a 24.86% increase from fiscal 2022.
- Penumbra, Inc apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $38.92M, a 40.57% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.21M 10-Q · filed 2026-07-30 | $30.40M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $17.19M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $59.52M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $14.37M 10-Q · filed 2025-11-05 | $28.38M derived: sum of 2 quarters · filed 2026-07-30 | $44.82M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $14.01M 10-Q · filed 2026-07-30 | $30.44M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $16.44M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $45.60M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $9.98M 10-Q · filed 2025-11-05 | $19.26M derived: sum of 2 quarters · filed 2025-11-05 | $34.71M derived: sum of 3 quarters · filed 2025-11-05 | |
| 2024-06-30 | $9.28M 10-Q · filed 2025-11-05 | $24.73M derived: sum of 2 quarters · filed 2025-11-05 | ||
| 2024-03-31 | $15.46M 10-Q · filed 2025-11-05 | |||
| 2023-12-31 | $48.59M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $12.10M 10-Q · filed 2024-10-30 | $24.76M derived: sum of 2 quarters · filed 2024-10-30 | $38.54M derived: sum of 3 quarters · filed 2024-10-30 | |
| 2023-06-30 | $12.65M 10-Q · filed 2024-10-30 | $26.44M derived: sum of 2 quarters · filed 2024-10-30 | ||
| 2023-03-31 | $13.78M 10-Q · filed 2024-10-30 | |||
| 2022-12-31 | $38.92M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $9.37M 10-Q · filed 2023-11-02 | $18.39M derived: sum of 2 quarters · filed 2023-11-02 | $29.10M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $9.02M 10-Q · filed 2023-11-02 | $19.74M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $10.72M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $65.48M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $6.94M 10-Q · filed 2022-11-03 | $17.08M derived: sum of 2 quarters · filed 2022-11-03 | $24.17M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $10.14M 10-Q · filed 2022-11-03 | $17.23M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $7.09M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $26.53M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | $5.79M 10-Q · filed 2021-11-03 | $11.53M derived: sum of 2 quarters · filed 2021-11-03 | $18.30M derived: sum of 3 quarters · filed 2021-11-03 | |
| 2020-06-30 | $5.74M 10-Q · filed 2021-11-03 | $12.51M derived: sum of 2 quarters · filed 2021-11-03 | ||
| 2020-03-31 | $6.77M 10-Q · filed 2021-11-03 | |||
| 2019-12-31 | $21.01M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $5.69M 10-Q · filed 2020-11-02 | $10.71M derived: sum of 2 quarters · filed 2020-11-02 | $16.16M derived: sum of 3 quarters · filed 2020-11-02 | |
| 2019-06-30 | $5.01M 10-Q · filed 2020-11-02 | $10.47M derived: sum of 2 quarters · filed 2020-11-02 | ||
| 2019-03-31 | $5.46M 10-Q · filed 2020-11-02 | |||
| 2018-12-31 | $18.45M 10-K · filed 2021-02-23 | |||
| 2018-09-30 | $4.44M 10-Q · filed 2019-11-07 | $9.52M derived: sum of 2 quarters · filed 2019-11-07 | $13.96M derived: sum of 3 quarters · filed 2019-11-07 | |
| 2018-06-30 | $5.08M 10-Q · filed 2019-11-07 | $9.52M derived: sum of 2 quarters · filed 2019-11-07 | ||
| 2018-03-31 | $4.43M 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $17.51M 10-K · filed 2020-02-26 | |||
| 2016-12-31 | $14.66M 10-K · filed 2019-02-26 | |||
| 2015-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $7.61M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $5.13M 10-Q · filed 2015-11-12 | |||
| 2014-12-31 | $1.43M 10-K · filed 2017-02-28 | |||
| 2013-12-31 | $886.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |